These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29744228)

  • 41. Antibiotic-resistant enterococci.
    Gray JW; Pedler SJ
    J Hosp Infect; 1992 May; 21(1):1-14. PubMed ID: 1351492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections.
    Hemapanpairoa J; Changpradub D; Santimaleeworagun W
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
    Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.
    Bethea JA; Walko CM; Targos PA
    Ann Pharmacother; 2004 Jun; 38(6):989-91. PubMed ID: 15100393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review.
    Marino A; Munafò A; Zagami A; Ceccarelli M; Campanella E; Cosentino F; Moscatt V; Cantarella G; Di Mauro R; Bernardini R; Nunnari G; Cacopardo B
    IDCases; 2022; 28():e01462. PubMed ID: 35265458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.
    Ibrahim SL; Zhang L; Brady TM; Hsu AJ; Cosgrove SE; Tamma PD
    Clin Infect Dis; 2015 Oct; 61(7):1119-24. PubMed ID: 26082503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation, characterization, and comparative genomic analysis of a phage infecting high-level aminoglycoside-resistant (HLAR)
    Nasr Azadani D; Zhang D; Hatherill JR; Silva D; Turner JW
    PeerJ; 2020; 8():e9171. PubMed ID: 32509458
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
    J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
    Antony SJ; Matherin P; Stratton C
    Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of aminoglycoside resistance and virulence genes among Enterococcus spp. isolated from a hospital in China.
    Li W; Li J; Wei Q; Hu Q; Lin X; Chen M; Ye R; Lv H
    Int J Environ Res Public Health; 2015 Mar; 12(3):3014-25. PubMed ID: 25768240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark].
    Olesen HV; Møller JK
    Ugeskr Laeger; 2002 Apr; 164(18):2386-90. PubMed ID: 12024841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin.
    Elwood RL; Spencer SE
    Ann Pharmacother; 2006 Feb; 40(2):347-50. PubMed ID: 16449537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversity among high-level aminoglycoside-resistant enterococci.
    Papaparaskevas J; Vatopoulos A; Tassios PT; Avlami A; Legakis NJ; Kalapothaki V
    J Antimicrob Chemother; 2000 Mar; 45(3):277-83. PubMed ID: 10702545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotics in neonatal infections: a review.
    Fanos V; Dall'Agnola A
    Drugs; 1999 Sep; 58(3):405-27. PubMed ID: 10493270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland.
    Talaga K; Odrowąż-Konduracka D; Paradowska B; Jagiencarz-Starzec B; Wolak Z; Bulanda M; Szczypta A
    Adv Clin Exp Med; 2018 Jan; 27(1):111-117. PubMed ID: 29521051
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Brown Gandt A; Griffith EC; Lister IM; Billings LL; Han A; Tangallapally R; Zhao Y; Singh AP; Lee RE; LaFleur MD
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.